Corticosteroid injections in patients with trochanteric pain syndrome: open label randomized clinical trial in general practice.
Completed
- Conditions
- Trochanteric pain, also known as trochanteric bursitis or pseudotrochanteric bursitis
- Registration Number
- NL-OMON20947
- Lead Sponsor
- Erasmus Medical Center, Department of General Practice
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
Patients aged 18 till 80 consulting the general practitioner with trochanteric hip pain existing longer then one week, with the following signs:
1. Severe local pain by pressure at the trochanter major, but unsure whether the patient recognizes this as the pain he/she consulted for;
Exclusion Criteria
1. Patients who don’t understand the questionnaires because of inadequate mastering of Dutch language or cognitive disorders;
2. Patients who presented themselves in the previous year to the GP with the same complaints;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Experienced recovery (7 points Likert scale) and severity of pain (0-10 VAS) at 3 months follow up.
- Secondary Outcome Measures
Name Time Method 1. Disease specific outcomes of pain and function (WOMAC/HOOS), at 3 and 12 months follow up;<br /><br>2. Primary outcomes at 6 weeks and at 6, 9 and 12 months follow-up;<br /><br>3. Cost effectiveness over 12 months of follow-up. Costs will be estimated by medical consumption, and productivity loss (PRODISC).